Howard Capital Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$703K Buy
8,981
+3,850
+75% +$311K 0.01% 291
2026
Q1
$445K Sell
5,131
-5,013
-49% -$480K 0.01% 238
2025
Q4
$974K Buy
10,144
+54
+0.5% +$5.25K 0.01% 250
2025
Q3
$961K Buy
10,090
+324
+3% +$29.8K 0.01% 233
2025
Q2
$851K Buy
9,766
+1,810
+23% +$153K 0.01% 242
2025
Q1
$715K Sell
7,956
-1,225
-13% -$110K 0.02% 231
2024
Q4
$733K Buy
+9,181
New +$795K 0.01% 251

Other funds holding MDT

Howard Capital Management's MDT Position: Q2 2026 in Review

Howard Capital Management increased its Medtronic (MDT) stake by 75% in Q2 2026, buying an estimated $311K and bringing the position to 8,981 shares worth $703K. The position accounts for 0.01% of the portfolio, ranked #291.

Howard Capital Management first reported a position in MDT in Q4 2024 and has held it in 7 quarters since. The position peaked at $974K in Q4 2025. 2,128 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Howard Capital Management held 8,981 shares of Medtronic worth $703K as of Q2 2026.
  • Howard Capital Management bought 3,850 Medtronic shares in Q2 2026, an estimated $311K.
  • Medtronic made up 0.01% of Howard Capital Management's portfolio in Q2 2026, its #291 holding.
  • Howard Capital Management first reported a position in Medtronic in Q4 2024 and has held it in 7 quarters since.
  • Howard Capital Management's Medtronic position peaked at $974K in Q4 2025.
  • 2,128 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Howard Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.